A Phase 3 interventional study of Brief Intervention and Diagnostic assessment in Risk Drinking,Diabetes, Hypertension, Osteoporosis, Infertility, sponsored by Brigham and Women's Hospital. Completed at 1 site in United States. Open to female participants aged 21 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-05-07.
Sponsored by Brigham and Women's Hospital · Phase 3, Interventional, and Prevention
The purpose of this randomized trial is to test the effectiveness of screening and brief intervention for risk drinking by nonpregnant women with specific medical problems exacerbated by excessive alcohol consumption. The medical problems are female factor infertility, hypertension, diabetes, and osteoporosis, conditions that are costly to treat and difficult to manage. Just as pregnant women are thought to be highly motivated to modify their alcohol consumption, so women with specific medical problems worsened by alcohol intake are an appropriate group to receive a brief intervention.
1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.
This study's enrollment of 611 is above the median of 95 across 1,133 interventional studies indexed under Osteoporosis.
Browse Osteoporosis studies →Brigham and Women's Hospital is the lead sponsor of 1,236 studies on the registry; 224 are open to participants now.
Of its 116 completed or terminated interventional studies of FDA-regulated products, 64 (55%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Diagnostic assessment with brief intervention and 3, 6, and 12 month follow-up
Behavioral: Brief Intervention
Diagnostic assessment with 12 month follow-up
Behavioral: Diagnostic assessment
Diagnostic assessment followed by a single session Brief Intervention with 3, 6, and 12 month follow-up
Single session diagnostic assessment with 12 month followup
Drinking outcome
Time frame: 12 months post enrollment
This study is completed, as verified in May 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham and Women's Hospital